CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies
| Image |  |
|---|---|
| Description | scientific article published on 8 March 2010 |
| Author/s |
author: Martha Q Lacy Mark R Litzow |
| Publication date | March 8, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |